Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real Life Study of Dolutegravir Plus Lamivudine in HIV-1-Infected Treatment-Naive Patients

NCT04002323 is registered in ClinicalTrials.gov with University Hospital Virgen de las Nieves as lead sponsor.

NCT NCT04002323
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04002323 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real Life Study of Dolutegravir Plus Lamivudine in HIV-1-Infected Treatment-Naive Patients
Lead sponsor
University Hospital Virgen de las Nieves
Phase
Observational
Overall status
Completed
Start date
May 7, 2019
Completion date
March 31, 2022
Enrollment
88 (actual)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

hiv-1-infection